Dividend-adjusted total return · S&P 500 uses VOO · Oct 6, 2026 – Nov 4, 2026KURES&P 500 · VOO
KraneShares MSCI All China Health Care Index ETFKURE
$18.63
+6.6% last session
+9.3% YTD
Data as of 11/4/20264:00 PM ET · End-of-day
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +6.6% | −4.4% | +6.6% | +9.3% | +0.6% | +6.9% | −35.9% | −8.0% |
| Peer average | +4.0% | −4.3% | −11.1% | −11.5% | −14.2% | +23.7% | −24.5% | — |
| S&P 500 · VOO | +1.6% | −1.6% | 0.0% | +13.4% | +13.5% | +91.7% | +81.2% | — |
Key Statistics
Open all fund facts →- AUM
- $113M
- Expense ratio
- 0.79%
- Distribution yield
- 3.8%
- NAV
- $18.32
- Volume
- 53K
- Avg. volume 30D
- 101K
- High today
- $18.66
- Low today
- $18.39
- Previous close
- $17.47
- 52-week high
- $19.93
- 52-week low
- $14.38
- Our risk indicator
- 4/5
KURE in One Breath
KURE Among China ETFs
YTDEnd-of-day Nov 5, 2026 · 25 China ETFs by YTD
$10,000 in KURE
5Y$10,000 in KURE became
$6,411
In the S&P 500 (VOO)
$18,115
Total return, dividends in · Oct 27, 2021 – Nov 4, 2026 · S&P 500 uses VOO
KURE’s Top Holdings
Today6160.HKBeone Medicines8.6%1801.HK7.9%2269.HK7.1%603259.SS5.4%600276.SS4.9%300760.SZ4.8%9926.HK3.9%1177.HK3.7%1093.HK3.4%3692.HK3.1%2359.HK3.1%000538.SZ2.7%688271.SS2.6%1548.HK2.6%300015.SZ2.2%600436.SS2.2%1530.HK2.1%6990.HK1.9%002422.SZ1.8%1099.HK1.7%300759.SZ1.6%300832.SZ1.4%31 more
6160.HKBeone Medicines8.6%1801.HK7.9%2269.HK7.1%603259.SS5.4%600276.SS4.9%300760.SZ4.8%9926.HK3.9%1177.HK3.7%1093.HK3.4%3692.HK3.1%2359.HK3.1%41 more
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsOther
KraneShares KURE · 53 holdings · tile size = share of the fund · as of Nov 4, 2026
What KURE Holds
TodayBiotechnology38.5%
6160.HK 8.6 · 1801.HK 7.9 · 2269.HK 7.1 · 9926.HK 3.9 · 1548.HK 2.6 · 1530.HK 2.1 · 6990.HK 1.9
Drug Manufacturers - Specialty & Generic10.6%
600276.SS 4.9 · 3692.HK 3.1 · 000538.SZ 2.7
Medical - Diagnostics & Research8.4%
603259.SS 5.4 · 2359.HK 3.1
Drug Manufacturers - General5.6%
1093.HK 3.4 · 600436.SS 2.2
Medical - Devices4.8%
300760.SZ 4.8
Medical - Pharmaceuticals3.7%
1177.HK 3.7
Medical - Specialties2.6%
688271.SS 2.6
KraneShares KURE · share of the fund by industry · as of Nov 4, 2026
Beone’s Share of KURE
Today8.6%
$86 of every $1,000 in KURE is Beone
Beone held by KURE
$9.7M
KraneShares KURE · each square = $10 of $1,000 · as of Nov 4, 2026
KURE’s Share of China ETFs
Today0.6%
of the $19.1B in 25 China ETFs
$113M0.6%
$5.8B30.2%
$4.4B23.2%
$8.8B45.9%
China ETF AUM · Nov 5, 2026
KURE Fee per $100 vs Peers
TodayExpense ratio · China peers · Nov 5, 2026
Inside KURE
53 holdings · as of Nov 4, 2026KURE
KraneShares MSCI All China Health Care Index ETF
TodayBiotechnology38.5%6160.HKBeone Medicines8.6%1801.HK7.9%2269.HK7.1%9926.HK3.9%1548.HK2.6%Drug Manufacturers - Specialty10.6%600276.SS4.9%3692.HK3.1%000538.SZ2.7%Medical - Diagnostics8.4%603259.SS5.4%Drug Manufacturers - General5.6%1093.HK3.4%Medical - Devices4.8%300760.SZ4.8%Medical - Pharmaceuticals3.7%1177.HK3.7%Medical - Specialties2.6%688271.SS2.6%Medical - Care Facilities2.2%Medical - Distribution1.7%Other21.8%5 more
Biotechnology38.5%6160.HK8.6%1801.HK7.9%2269.HK7.1%4 moreDrug Manufacturers - Specialty10.6%600276.SS4.9%Medical - Diagnostics8.4%603259.SS5.4%Drug Manufacturers - General5.6%Medical - Devices4.8%300760.SZ4.8%Medical - Pharmaceuticals3.7%1177.HK3.7%Medical - Specialties2.6%Medical - Care Facilities2.2%Other21.8%13 more
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 6160.HK | Beone Medicines | 8.60% |
| 2 | 1801.HK | Innovent Biologics | 7.94% |
| 3 | 2269.HK | Wuxi Biologics Cayman | 7.11% |
| 4 | 603259.S | Wuxi Apptec -A | 5.38% |
| 5 | 600276.S | Jiangsu Hengrui Pharmaceut-a | 4.89% |
| 6 | 300760.S | Shenzhen Mindray Bio-medic-a | 4.84% |
| 7 | 9926.HK | Akeso | 3.85% |
| 8 | 1177.HK | Sino Biopharmaceutical | 3.68% |
| 9 | 1093.HK | Cspc Pharmaceutical Group LT | 3.41% |
| 10 | 3692.HK | Hansoh Pharmaceutical Group | 3.06% |
BiotechnologyDrug Manufacturers - SpecialtyMedical - DiagnosticsDrug Manufacturers - GeneralMedical - DevicesMedical - PharmaceuticalsMedical - SpecialtiesMedical - Care FacilitiesMedical - DistributionOther
KraneShares KURE · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 75.6%
How It Compares
KURE
KraneShares MSCI All China Health Care Index ETF’s Peers
YTDChina peers · YTD and past-year returns · as of Nov 5, 2026 · sorted by AUM
Head to Head
Put KURE head to head with MCHI →MCHI vs KURE
YTDYear to date
KURE wins+22.9 pts
Past year
KURE wins+18.0 pts
Fee
MCHI winslower fee
Yield
KURE wins+1.7 pts
AUM
MCHI51.2× more
3–1KURE wins
iShares MCHI and KraneShares KURE · year-to-date · as of Nov 5, 2026 · AUM not scored
China vs Thematic
Average · YTDMCHI
−13.6%
KURE
+9.3%
Thematic average
+7.7%
MCHI, KURE and the average thematic ETF · YTD return · as of Nov 5, 2026
KURE vs VOO
YTDKURE · KraneShares MSCI All China Health Care Index
+9.3%
VOO · S&P 500
+13.4%
Gap
4.0 pts
KraneShares KURE and Vanguard VOO · YTD total return · as of Nov 5, 2026
KURE vs Its Peer Average
YTDKUREAvsBPeer average
1D+6.6%+4.0%
1M−4.4%−4.3%
3M+6.6%−11.1%
YTD+9.3%−11.5%
1Y+0.6%−14.2%
3Y+6.9%+23.7%
5Y−35.9%−24.5%
4–3KURE wins
24 China peers · each row scaled to its leader
The Details
KURE
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y28.18%
Deepest drop · 1Y−24.6%
Lowest point · 5Y−57.5%
52-week range
$18.63
$14.38−6.5% from the high$19.93
KraneShares KURE · past-year price moves · as of Nov 5, 2026
KURE
Fund Facts
Today2018launched Jan 31
Tracks[…]
Exchange · CUSIPAMEX · 500767835
StructureETF
Leverage1x
Cost on $10,000$79 a year
Go deeper
KraneShares KURE · fund facts · as of Nov 5, 2026
KURE
Payouts by Year
8Y$0.71per share, Dec 2025
Distribution yield3.8%
PaidOnce a year, in December
Latest ex-date · paidDec 22 · Dec 23, 2025
8 payouts added up$5.21 a share
KraneShares KURE · distributions by ex-date · 2018–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗SEC reported portfolio · 2025-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗SEC reported portfolio · 2024-06-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-03-31 ↗SEC reported portfolio · 2023-12-31 ↗SEC reported portfolio · 2023-09-30 ↗SEC reported portfolio · 2023-06-30 ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$18.32
Premium / discount[…]
Median spread · 30D[…]
Volume today53K
Average volume · 30D101K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.79%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$79.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 23, 2025 | $0.71 |
| Dec 17, 2024 | Dec 18, 2024 | $0.18 |
| Dec 18, 2023 | Dec 20, 2023 | $0.11 |
| Dec 28, 2022 | Dec 30, 2022 | $0.0104 |
| Dec 29, 2021 | Dec 31, 2021 | $4.05 |
| Dec 29, 2020 | Dec 31, 2020 | $0.0001 |
| Dec 27, 2019 | Dec 31, 2019 | $0.0573 |
| Dec 26, 2018 | Dec 28, 2018 | $0.0760 |
Issuer contentFrom KraneSharesHear the strategy from the people behind KURE.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →